BRIEF—Immunomedics CMO makes swift exit

A year after becoming chief medical officer of Immunomedics, Rob Iannone is to leave the role and company.

Dr Iannone joined the New Jersey-based antibody-drug conjugates specialist from AstraZeneca’s MedImmune specialist in April 2018.

The reason given for his departure was that he wishes to take up a career opportunity closer to his home and family in Pennsylvania.

MedImmune has started the search for a replacement and also has identified consultants who will provide support during the interim period.